ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Anagrelide Hydrochloride Capsule shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2025-11-19 · last update 2025-11-19

Manufacturers: Teva Pharmaceuticals USA, Inc.

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60)Teva Pharmaceuticals USA, Inc.To Be Discontinued
 —A business decision was made to discontinue manufacture of the drug.Posted 11/19/2025
Updated 11/19/2025
Discontinued 11/19/2025
Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60)Teva Pharmaceuticals USA, Inc.To Be Discontinued
 —A business decision was made to discontinue manufacture of the drug.Posted 11/19/2025
Updated 11/19/2025
Discontinued 11/19/2025

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)